Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs ProShares Ultra QQQ ETF (QLD) Price & Performance

Abeona Therapeutics IncTrade
ProShares Ultra QQQ ETFTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs ProShares Ultra QQQ ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ProShares Ultra QQQ ETF trades at $92.21. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ProShares Ultra QQQ ETF nearer its low. Which is the better fit depends on your goals.

ABEOQLD
Market Cap
$421.19M
Sector
HealthLeveraged / Inverse
52-Week High
$7.45$100.53
52-Week Low
$4.17$57.16
Enterprise Value
$276.10M

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About ProShares Ultra QQQ ETF

QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on QLD